HOME >> MEDICINE >> NEWS
Delayed-release stimulant used to treat ADHD may be less subject to abuse

A team led by Massachusetts General Hospital (MGH) researchers has found that a delayed-release stimulant used to treat attention-deficit hyperactivity disorder (ADHD) may be less likely to be abused than other stimulant drugs. Study participants taking therapeutic oral doses of Concerta, a once-daily form of the drug methylphenidate, did not report perceiving and enjoying the drug's subjective effects, features that are associated with a medication's potential for abuse. The report appears in the March 2006 issue of The American Journal of Psychiatry.

"We know that drugs that cause euphoria are potentially abusable, and euphoria requires rapid delivery to the brain. Using sophisticated PET scan imaging, we were able to examine the rate of delivery of both rapid- and delayed-release formulations of methylphenidate and correlate those results with how the drugs felt to study volunteers," says Thomas Spencer, MD, of the MGH Pediatric Psychopharmacology Unit, the paper's lead author. "The ability to show that rate of brain delivery may determine abuse potential is important to our understanding of the safety of different formulations."

Methylphenidate and other stimulant drugs used to treat ADHD act by blocking the dopamine transporter, a molecule on brain cells that takes up the neurotransmitter dopamine, raising its level in the brain. Studies have shown that the brains of ADHD patients have abnormal regulation of dopamine, which plays a key role in the control of movement, behavior and attention. While stimulants are effective for controlling ADHD symptoms, the drugs are also subject to abuse, so the current study was designed to compare the abuse potential of two formulations of methylphenidate.

The researchers compared a traditional, quick-release form of the drug with Concerta, a formulation that is released over 12 hours to produce a gradual increase in blood levels. With Concerta, the drug passes slowly through a hole in capsul
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
1-Mar-2006


Page: 1 2

Related medicine news :

1. Investigational nonstimulant Guanfacine XR significantly improved child, adolescent ADHD symptoms
2. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
3. Study examines risk for misuse of ADHD stimulant medications
4. Spot on treatment for acne
5. Using coxibs and NSAIDs to treat osteoarthritis
6. New treatment boosts muscle function in myasthenia gravis
7. New treatment effective in counteracting cocaine-induced symptoms
8. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
9. Despite claims, not all probiotics can treat diarrhea say experts
10. Preventive treatments in elderly people needs rethinking
11. Osteoporosis screening and treatment may be cost-effective for selected older men

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... With Valentine’s ... sexually transmitted disease (STD) testing service, is sharing 7 tips to ensure ‘Safe Sex’: ... especially if you’re going to engage in safe sex. Having clear, open, and honest ...
(Date:2/13/2019)... , ... February 13, 2019 , ... Infertility is an issue for 1 in 6 ... A startling 2017 study outlining the sharp decline in male sperm count over the last ... , garnering worldwide attention and causing panic that we are in the midst of a ...
(Date:2/13/2019)... Ill. (PRWEB) , ... February 13, 2019 , ... Surgery ... significantly effective and safe treatment for obstructive sleep apnea (OSA), resulting in benefits that ... cardiovascular risk, according to a new study. , MMA should be regarded as the ...
(Date:2/12/2019)... ... February 12, 2019 , ... ... consulting organization, devoted to helping hospital leaders, staff, and physicians achieve excellence, ... . The website now features a streamlined design, improved functionality, and robust ...
(Date:2/12/2019)... ... February 12, 2019 , ... Surgical Theater is ... satisfaction, improve patient retention, and reduce patient outmigration for attendees of the Healthcare ... provides Surgical Theater with a great venue to highlight the value of patient ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... ... 2019 , ... Sensible Surrogacy today has launched a new ... couples who are unable to afford the staggering cost of surrogacy in the ... America or Eastern Europe for legal and secure surrogacy procedures. However North American ...
(Date:2/13/2019)... ... February 13, 2019 , ... Wound Care centers across the ... EHR software as an app inside their hospital’s EHR, substantially improving continuity of ... (electronic health record) pioneer, will soon launch its award-winning software as an “app” ...
(Date:2/13/2019)... ... February 13, 2019 , ... Abu Dhabi ... Private Partnership (PPP) between the Department of Health-Abu Dhabi (DoH) and Injazat Data ... Information Exchange system (HIE), a centralized platform to streamline healthcare connectivity for the ...
Breaking Medicine Technology:
Cached News: